**Core Concept**
Dysthyroid ophthalmopathy, also known as Graves' orbitopathy, is an autoimmune inflammatory condition associated with Graves' disease that affects the tissues around the eye, including the eyelids, eye socket, and lacrimal gland.

**Why the Correct Answer is Right**
The condition is characterized by an inflammatory process involving the orbital tissues, leading to swelling, redness, and protrusion of the eye (exophthalmos). This is due to the infiltration of immune cells and the production of autoantibodies against the thyroid-stimulating hormone receptor (TSH-R), which activates the thyroid-stimulating hormone receptor on the orbital fibroblasts, leading to the release of cytokines and growth factors that promote inflammation and tissue remodeling.

**Why Each Wrong Option is Incorrect**
**Option A:** Dysthyroid ophthalmopathy is indeed more common in women than men, so this statement is correct and not the answer we're looking for. However, I will still provide an explanation for the sake of completeness: This is because women are more likely to develop Graves' disease, the underlying autoimmune condition that triggers dysthyroid ophthalmopathy.
**Option B:** The statement that dysthyroid ophthalmopathy is not associated with thyroid function is incorrect. In fact, the severity of dysthyroid ophthalmopathy is often correlated with the severity of hyperthyroidism in Graves' disease.
**Option C:** The statement that dysthyroid ophthalmopathy is not responsive to corticosteroids is incorrect. Corticosteroids are often used as a first-line treatment for dysthyroid ophthalmopathy to reduce inflammation and prevent further tissue damage.

**Clinical Pearl / High-Yield Fact**
The clinical correlation between dysthyroid ophthalmopathy and Graves' disease highlights the importance of a thorough thyroid evaluation in patients with suspected dysthyroid ophthalmopathy. A high index of suspicion and a thorough clinical examination are essential for early diagnosis and treatment.

**Correct Answer:** B.